Sort
10,766 grants matching “checkpoint inhibitor”
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targ
$0Basic Sciences · Z01 · FY2005 · BC
Cell Cycle Regulation &Nuclear Architecture In Yeast
$0Diabetes, Digestive, Kidney Diseases · Z01 · FY2005 · DK
Assessment of cardiotoxicity in Immunity Checkpoint Blockers and other cancer therapies
$0Mary Susan Vaughan Sarrazin · Iowa City Va Medical Center · I21 · FY2020 · VA
Autoinflammation in Human Melanoma
$0Mayumi Fujita · Va Eastern Colorado Health Care System · I01 · FY2021 · VA
Lung Dysbiosis and Increased Host Susceptibility to Respiratory Pathogens
$0Benjamin G Wu · Va Medical Center · IK2 · FY2024 · VA
Overcoming BRAF and MEK Inhibitors Resistance in Advanced Melanoma
$0Niramol Savaraj · Miami Va Health Care System · I01 · FY2019 · VA
Clinically Actionable Neoantigens in Non-Small Cell Lung Cancer
$0Steven M. Dubinett · Va Greater Los Angeles Healthcare System · I01 · FY2021 · VA
Cytomegalovirus-based Immunotherapy for Prostate Cancer
$0Richard B Alexander · Baltimore Va Medical Center · I01 · FY2015 · VA
Mechanisms of Nucleic Acid Enzymes - Pol Beta and Mammal
$0Samuel H Wilson · Environmental Health Sciences · Z01 · FY2006 · ES
Impact of N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on the Progression of Melanoma
$0Joanne Kramer Tobacman · Jesse Brown Va Medical Center · I01 · FY2022 · VA
Induction of Senescence using Dexamethasone to re-sensitize NSCLC to anti-PD1 therapy
$0Nithya Ramnath · Veterans Health Administration · I01 · FY2019 · VA
1 Z01 HD008740-05 LGRD
$0Mary C. Dasso · Child Health And Human Development · Z01 · FY2006 · HD
Phage Display for Improved Peptide-Based Tumor Targeting and Imaging Agents
$0Charles J Smith · Harry S. Truman Memorial Va Hospital · I01 · FY2025 · VA
BLRD Research Career Scientist Award Application
$0Ricardo C Aguiar · South Texas Veterans Health Care System · IK6 · FY2025 · VA
Flt3l gene-modified cDC1 in situ vaccination in NSCLC: mechanisms and therapeutic application
$0Ramin Salehi-Rad · Va Greater Los Angeles Healthcare System · IK2 · FY2023 · VA
BLRD Research Career Scientist Award Application
$0Ricardo C Aguiar · South Texas Veterans Health Care System · IK6 · FY2024 · VA
Stratification of Pancreatic Cancer Subpopulations for Effective Immunotherapy
$0Qizhi C. Yao · Michael E Debakey Va Medical Center · I01 · FY2023 · VA
Defining the role of the EGFR in MHC expression and anti-tumor immune responses.
$0Brian P Pollack · Veterans Health Administration · I01 · FY2019 · VA
Phage Display for Improved Peptide-Based Tumor Targeting and Imaging Agents
$0Charles J Smith · Harry S. Truman Memorial Va Hospital · I01 · FY2024 · VA
Potentiation of Immunotherapy with targeted nanoporphyrin in bladder cancer
$0Chong-Xian Pan · Va Boston Health Care System · I01 · FY2021 · VA
A Phase 2 study of a Checkpoint Inhibitor in Men with Progressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation
$0Matthew B Rettig · Va Greater Los Angeles Healthcare System · I01 · FY2022 · VA
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tulmimetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
$0Daniel Sanghoon Shin · Va Greater Los Angeles Healthcare System · I01 · FY2023 · VA
Preclinical investigation of PI3K inhibition and immune checkpoint blockade combination therapy for treatment of Merkel cell carcinoma using humanized mouse models
$0Ling Gao · Veterans Health Administration · I01 · FY2022 · VA
BLRD Research Career Scientist Award Application
$0Sushanta K Banerjee · Kansas City Va Medical Center · IK6 · FY2022 · VA
Programming Durable Immune Responses in Lung Cancer
$0Sherven Sharma · Va Greater Los Angeles Healthcare System · I01 · FY2020 · VA